Bacteria-Responsive Nanostructured Drug Delivery Systems for Targeted Antimicrobial Therapy.

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Microbiology

Background:

• Bacteria develop resistance to host defenses and antimicrobial treatments.
• Antimicrobial resistance is a growing global health concern.
• Conventional antimicrobials face challenges due to resistance and broad-spectrum activity.

Purpose of the Study:

• To review bacteria-responsive nanostructured drug delivery systems.
• To highlight their advantages over conventional antimicrobials.
• To discuss recent preclinical studies and future potential.

Main Methods:

• Development of nanocarriers that respond to bacterial presence or components.
• Engineering systems with triggers like bacterial enzymes, toxins, or surface molecules.
• Utilizing various nanomaterials (lipid-based, metal, polymer, inorganic) for drug encapsulation and targeted release.
• Investigating dual therapeutic effects and multi-mechanism antimicrobial strategies.

Main Results:

• Bacteria-responsive nanosystems demonstrate enhanced selectivity and reduced off-target effects.
• These systems improve biofilm penetration and intracellular drug accumulation.
• Preclinical studies validate the efficacy of these smart drug delivery platforms.
• Integrated antimicrobial mechanisms in nanosystems reduce resistance development potential.

Conclusions:

• Bacteria-responsive nanodrug delivery systems represent a promising alternative to conventional antimicrobials.
• They offer precise activation at infection sites, minimizing side effects.
• These advanced systems hold potential for personalized therapy and overcoming antimicrobial resistance.